[144] Evolv Technologies Holdings, Inc. SEC Filing
Rhea-AI Filing Summary
EVLV filed a Form 144 notifying a proposed sale of Class A Common stock. The notice lists 161,490 shares tied to a stock option exercise (cash) dated 03/06/2026 and 91,771 shares from restricted stock vesting dated 03/01/2026. The filing also reports past sales by Michael P. Ellenbogen: 80,745 shares on each of 12/15/2025, 01/16/2026, and 02/17/2026.
Positive
- None.
Negative
- None.
Insights
Form 144 registers planned insider sales and recent dispositions.
The filing lists proposed sales of 161,490 shares via stock option exercise and 91,771 shares from restricted stock vesting in early March 2026. It also documents three prior dispositions of 80,745 shares each by Michael P. Ellenbogen in Dec 2025–Feb 2026.
These entries are procedural under Section 144; timing and settlement depend on market transactions and compliance with resale rules.
Insider activity shows staged dispositions and scheduled vesting.
The record pairs a planned option exercise sale of 161,490 shares with a separate vesting event of 91,771 shares; prior open-market sales of 80,745 occurred on three dates earlier. The filing identifies the broker as J.P. Morgan Securities LLC.
Investor impact depends on actual market sales; the filing itself is a required notification, not a guarantee of volume or timing.